2012
DOI: 10.1111/cup.12027
|View full text |Cite
|
Sign up to set email alerts
|

De novo myeloid sarcoma in a 4‐month‐old infant: a case report and review of the literature

Abstract: Myeloid sarcoma is a rare tumor of immature myeloid cells in an extramedullary site. Myeloid sarcoma may present in a variety of locations; skin is one of the common sites. It may precede or occur concurrently with acute myeloid leukemia, chronic myeloid leukemia, other forms of myeloproliferative disorders/myelodysplastic syndrome or de novo. We report a case of a 4-month-old female who presented with cutaneous lesions without evidence of leukemia, determined to be de novo myeloid sarcoma. She had erythematou… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 11 publications
(13 citation statements)
references
References 17 publications
0
12
0
1
Order By: Relevance
“…In 15-35% of cases, MS can appear concomitantly with AML, whereas, in 50% of cases MS appears following the diagnosis of AML. In rare instances (<1%), MS has also been diagnosed after allogenic stem cell transplantation (allo-SCT), which manifests as an isolated tumor with or without accompanying blood and bone marrow relapse [14,15].…”
Section: Epidemiologymentioning
confidence: 99%
“…In 15-35% of cases, MS can appear concomitantly with AML, whereas, in 50% of cases MS appears following the diagnosis of AML. In rare instances (<1%), MS has also been diagnosed after allogenic stem cell transplantation (allo-SCT), which manifests as an isolated tumor with or without accompanying blood and bone marrow relapse [14,15].…”
Section: Epidemiologymentioning
confidence: 99%
“…It may occur de novo or concurrently with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS) or a myeloproliferative disorder. Myeloid sarcoma can also be a manifestation of the relapse of the disease [ 2 4 ]. Non-effacing tissue leukemic infiltrates are distinguished from MS [ 1 ].…”
Section: Introductionmentioning
confidence: 99%
“…The t(8;21) karyotype is associated with AML solid tumors [ 3 ], but was not identified in this case. Granulocytic sarcoma may present as a sign of leukemic relapse in patients who have been previously diagnosed with AML, or who may not have received prior therapy, or as a de novo diagnosis in the absence of any previous pathology [ 4 ].…”
Section: Discussionmentioning
confidence: 99%